Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Operating Margin Growth (3y) (2022 - 2025)

Analysis

Evotec SE (EVO) Operating Margin Growth (3y) (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn -247.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 375.00
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn -362.00
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn -369.00
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn -218.00
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -6,191.00
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 1,551.00
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 289.00
10 VivoSim Labs 1.45 Mn 1.45 Mn - -973,444.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1,822.00
Sep 30, 2025 -3,493.00
Jun 30, 2025 -1,403.00
Mar 31, 2025 -29,117.00
Dec 31, 2024 -410.00
Sep 30, 2024 -1.11 Mn
Jun 30, 2024 4,910.00
Mar 31, 2024 -510,171.00
Dec 31, 2023 -620,848.00
Dec 31, 2022 -1,843.00